Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.

Galectin Therapeutics Inc Is A Clinical-Stage Biopharmaceutical Company. The Company Focuses On Drug Research And Development To Create New Therapies For Fibrotic Disease, Cancer, And Selected Other Diseases. Its Galectin-3 Inhibitor Is Belapectin (Gr-Md-02), Which Has Been Demonstrated In Preclinical Models To Reverse Liver Fibrosis And Cirrhosis.